FOF Capital
VC Fund
Haidian, China
FOF Capital is an investment management firm.
- Total investments:
- 20
- Last investment:
- Lead investor:
- 5%
Last updated:
For AI agents: llms.txt
Industries FOF Capital invests in
Stages FOF Capital invests in
Countries FOF Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
|
|||
4 more contacts available
Investment Focus
Industry
- Medical 5 (25%)
- Biotechnology 4 (20%)
- Manufacturing 4 (20%)
- Health Care 3 (15%)
- Pharmaceutical 3 (15%)
Stage
- Seed 5 (25%)
- Series A 3 (15%)
- Series B 3 (15%)
- Series C 2 (10%)
- Series D 2 (10%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Wang Chao
Co-Founder and Chairman
|
Co-Founder and Chairman | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Winglight Technology is a domestic provider of silicon photonics gyroscope chips and solutions. | Seed / Feb 02, 2026 | |
|
|
Yuanma Intelligent Pharmaceuticals is a biopharmaceutical business that focuses on circular mRNA (cmRNA) treatments, namely in vivo cmRNA CAR-T cell therapy. | $2.1M / Series A / Oct 20, 2025 | |
|
|
Yuanma Intelligent Pharmaceuticals is a biopharmaceutical business that focuses on circular mRNA (cmRNA) treatments, namely in vivo cmRNA CAR-T cell therapy. | $2.1M / Seed / Oct 20, 2025 | |
|
|
Titanium Robotics Technology specializing in the development and production of advanced robot hardware and solutions. It focuses on customized services, R&D, and production of robot hardware, aiming to create high-performance, industry standard products, develops lightweight, collaborative robots, humanoid robots, and exoskeletons, leading thesupply chain towards lightweight, miniaturization, and ease of use. | Seed / Jul 03, 2024 | |
|
|
Hengren Intelligent specializes in the invention, design, and selling of CD-SEM equipment. | Seed / Aug 14, 2023 | |
|
|
Dishi Medical is a company that manufactures Ophthalmic Medical Devices and other micro-assisted robots supported by biotechnology. | Seed / Jul 10, 2023 | |
|
|
Ubrigene is driven by the advancement of gene and cell therapy technologies through research and development represented by AAV vectors. It can provide a comprehensive solution for gene therapy industrialization. | $21.8M / Series C / Apr 19, 2023 | |
|
|
Furong Bio is a developer of innovative tumor immunology drugs. | $14.7M / Series A / Feb 06, 2023 | |
|
|
Furong Bio is a developer of innovative tumor immunology drugs. | $14.7M / Series A / Feb 06, 2023 | |
|
|
Ubrigene is driven by the advancement of gene and cell therapy technologies through research and development represented by AAV vectors. It can provide a comprehensive solution for gene therapy industrialization. | $14.7M / Series C / Dec 23, 2022 | |
| See all 20 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does FOF Capital invest in?
FOF Capital invests primarily in Medical, Biotechnology and Manufacturing startups, most often at Seed and Series A stage. Most of the 20 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact FOF Capital?
Public channels for FOF Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at FOF Capital?
The team at FOF Capital includes Wang Chao (Co-Founder and Chairman). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!